Form 8-K - Current report:
SEC Accession No. 0001789769-23-000004
Filing Date
2023-01-09
Accepted
2023-01-09 16:00:21
Documents
14
Period of Report
2023-01-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20230109.htm   iXBRL 8-K 43138
2 EX-99.1 a2023-01x09resumptionoftri.htm EX-99.1 10818
6 LOGO image_0.jpg GRAPHIC 2895
  Complete submission text file 0001789769-23-000004.txt   202631

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20230109.xsd EX-101.SCH 1890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20230109_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20230109_pre.xml EX-101.PRE 13036
8 EXTRACTED XBRL INSTANCE DOCUMENT til-20230109_htm.xml XML 11685
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 23518057
SIC: 2836 Biological Products, (No Diagnostic Substances)